European Archives - Page 351 of 1389 - European Medical Journal

Gut Microbiota Maturation Disrupted in Infants with Cystic Fibrosis

Findings revealed that microbiota maturation in cystic fibrosis is delayed, preventing the establishment of a stable, adult-like community.

Non-Invasive Markers Could Differentiate Complicated Appendicitis Early

Researchers have identified key biomarkers that could help distinguish between uncomplicated and complicated appendicitis, allowing for earlier and more accurate diagnosis. The study found that Red Cell Distribution Width (RDW), Mean Platelet Volume (MPV), and appendix diameter are reliable indicators of appendicitis severity.

New Study Uncovers Key Mechanisms in Psoriasis

Recent findings indicate that c-Rel expression is upregulated in psoriatic skin lesions and decreases following treatment.

Urinary DNA Test Shows High Accuracy for Bladder Cancer

Ultimately, these findings highlight the potential for urinary DNA methylation testing to improve early detection and diagnosis of bladder cancer.

Early COPD Detection Enhanced by Polygenic Risk Scoring

Adding genetic risk scores to traditional case-finding methods enhances the detection of undiagnosed COPD, improving early diagnosis and intervention.

Racial Disparities Persist in Access to Same-Day Breast Imaging

Study reveals racial differences in access to breast-imaging services.

HEALEY Trial: Pridopidine Fails to Slow ALS Progression

Pridopidine did not slow ALS progression in a 24-week trial. Findings highlight the need for continued research and alternative therapies.

Study Finds Donor Choice Influences Haploidentical Stem Cell Transplant Success

Donor age and cell dose significantly influence outcomes in haploidentical stem cell transplants, reveals new research.

PPARβ/δ Activation May Combat Insulin Resistance by Protecting Insulin Receptor Levels

Study has shed light on a potential pathway for combating insulin resistance.

Advancing Immunotherapy for Keratinocyte Carcinoma Prevention

Immune checkpoint inhibitors represent an exciting avenue for managing field cancerisation and reducing the keratinocyte carcinoma burden.